<DOC>
	<DOCNO>NCT01247012</DOCNO>
	<brief_summary>Prolonged use parenteral nutrition lead parenteral nutrition associate liver disease ( PNALD ) . The purpose study determine effect treatment small amount lipid minimization ) standard soybean oil base intravenous lipid emulsion ( Intralipid ) versus fish-oil base lipid emulsion ( Omegaven ) infant severe cholestasis .</brief_summary>
	<brief_title>Minimization IntraLipid Versus Omegaven</brief_title>
	<detailed_description>Infants meet eligibility randomize receive either 1g/kg/day Intralipid速 20 % 1g/kg/day Omegaven速 10 % . Infants randomize Intralipid速 whose conjugated bilirubin level rise &gt; 100umol/L cross receive 1g/kg/day Omegaven速 . Monitoring include liver function test ( AST , ALT , ALP , GGT , Conjugated Bilirubin ) , Fatty Acid Profile ( RBC serum fatty acid ; triene/tetraene ratio ) , INR ( coagulation profile ) cytokine measure ( inflammatory marker ) .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Cholestasis</mesh_term>
	<mesh_term>Soybean oil , phospholipid emulsion</mesh_term>
	<criteria>infant admit neonatal intensive care unit severe cholestasis , define conjugate bilirubin great 35 receive least 60 % calorie IV infusion expect require intravenous nutrition least additional 28 day sign consent hepatitis ( TORCH viral infection ) primary liver disease etiology cholestasis clinically severe bleed able manage routine measure lethal congenital abnormality congenital heart disease associate right heart dysfunction</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>6 Months</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>